JP4189048B2 - 複素環化合物 - Google Patents

複素環化合物 Download PDF

Info

Publication number
JP4189048B2
JP4189048B2 JP36788797A JP36788797A JP4189048B2 JP 4189048 B2 JP4189048 B2 JP 4189048B2 JP 36788797 A JP36788797 A JP 36788797A JP 36788797 A JP36788797 A JP 36788797A JP 4189048 B2 JP4189048 B2 JP 4189048B2
Authority
JP
Japan
Prior art keywords
group
carbon atoms
substituted
alkyl
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP36788797A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11193282A (ja
JPH11193282A5 (https=
Inventor
歩 栗本
哲広 荻野
肇 川上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Dainippon Pharma Co Ltd filed Critical Sumitomo Dainippon Pharma Co Ltd
Priority to JP36788797A priority Critical patent/JP4189048B2/ja
Publication of JPH11193282A publication Critical patent/JPH11193282A/ja
Publication of JPH11193282A5 publication Critical patent/JPH11193282A5/ja
Application granted granted Critical
Publication of JP4189048B2 publication Critical patent/JP4189048B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP36788797A 1997-12-26 1997-12-26 複素環化合物 Expired - Fee Related JP4189048B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP36788797A JP4189048B2 (ja) 1997-12-26 1997-12-26 複素環化合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP36788797A JP4189048B2 (ja) 1997-12-26 1997-12-26 複素環化合物

Publications (3)

Publication Number Publication Date
JPH11193282A JPH11193282A (ja) 1999-07-21
JPH11193282A5 JPH11193282A5 (https=) 2005-09-02
JP4189048B2 true JP4189048B2 (ja) 2008-12-03

Family

ID=18490454

Family Applications (1)

Application Number Title Priority Date Filing Date
JP36788797A Expired - Fee Related JP4189048B2 (ja) 1997-12-26 1997-12-26 複素環化合物

Country Status (1)

Country Link
JP (1) JP4189048B2 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7157465B2 (en) 2001-04-17 2007-01-02 Dainippon Simitomo Pharma Co., Ltd. Adenine derivatives
MXPA05003193A (es) * 2002-09-27 2005-06-08 Sumitomo Pharma Compuesto de adenina novedoso y uso del mismo.
JP2007504232A (ja) * 2003-09-05 2007-03-01 アナディス ファーマシューティカルズ インク Ｃ型肝炎ウイルス感染治療用のｔｌｒ７リガンド及びそのプロドラッグの投与
US8012964B2 (en) 2004-03-26 2011-09-06 Dainippon Sumitomo Pharma Co., Ltd. 9-substituted 8-oxoadenine compound
CN101304748A (zh) * 2005-08-22 2008-11-12 加利福尼亚大学董事会 Tlr激动剂
JP2009528989A (ja) 2006-02-17 2009-08-13 ファイザー・リミテッド Ｔｌｒ７変調剤としての３−デアザプリン誘導体
US8138172B2 (en) 2006-07-05 2012-03-20 Astrazeneca Ab 8-oxoadenine derivatives acting as modulators of TLR7
TW200831105A (en) 2006-12-14 2008-08-01 Astrazeneca Ab Novel compounds
CN101790380B (zh) 2007-02-07 2013-07-10 加利福尼亚大学董事会 合成tlr激动剂的缀合物及其应用
ES2457316T3 (es) 2007-03-19 2014-04-25 Astrazeneca Ab Compuestos 8-oxo-adenina 9 sustituidos como moduladores del receptor similares a toll (TLR7)
ES2373616T3 (es) 2007-03-19 2012-02-07 Astrazeneca Ab Compuestos de 8-oxo-adenina 9 sustituidos como moduladores del receptor de tipo toll (tlr7).
JPWO2008114819A1 (ja) 2007-03-20 2010-07-08 大日本住友製薬株式会社 新規アデニン化合物
AR065784A1 (es) * 2007-03-20 2009-07-01 Dainippon Sumitomo Pharma Co Derivados de 8-oxo adenina,medicamentos que los contienen y usos como agentes terapeuticos para enfermedades alergicas, antivirales o antibacterianas.
HRP20120895T1 (hr) 2007-05-08 2012-11-30 Astrazeneca Ab Imidazokinolini sa imuno-modulacijskim svojstvima
PE20091236A1 (es) 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
PE20091156A1 (es) 2007-12-17 2009-09-03 Astrazeneca Ab Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
WO2009091032A1 (ja) 2008-01-17 2009-07-23 Dainippon Sumitomo Pharma Co., Ltd. アデニン化合物の製造方法
WO2010088924A1 (en) 2009-02-06 2010-08-12 Telormedix Sa Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
GB0908772D0 (en) 2009-05-21 2009-07-01 Astrazeneca Ab New salts 756
AU2010250923A1 (en) 2009-05-21 2011-11-17 Astrazeneca Ab Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
JP5694345B2 (ja) 2009-10-22 2015-04-01 ギリアード サイエンシーズ， インコーポレイテッド Ｔｏｌｌ様受容体の調節因子
AU2011247358B2 (en) 2010-04-30 2014-10-30 Urogen Pharma Ltd. Phospholipid drug analogs
US9050319B2 (en) 2010-04-30 2015-06-09 Telormedix, Sa Phospholipid drug analogs
CN103370317B (zh) 2010-12-16 2015-10-07 阿斯利康(瑞典)有限公司 可用于治疗的咪唑并[4,5-c]喹啉-1-基衍生物
ES2627433T3 (es) 2010-12-17 2017-07-28 Sumitomo Dainippon Pharma Co., Ltd. Derivados de purina
JP6184423B2 (ja) 2012-05-18 2017-08-23 大日本住友製薬株式会社 カルボン酸化合物
PL3294740T3 (pl) 2015-05-08 2020-03-31 F. Hoffmann-La Roche Ag Nowe sulfonoimidoilopurynony i pochodne do leczenia i profilaktyki infekcji wirusowych
US11697851B2 (en) 2016-05-24 2023-07-11 The Regents Of The University Of California Early ovarian cancer detection diagnostic test based on mRNA isoforms
PL3504210T3 (pl) * 2016-08-29 2021-07-05 F. Hoffmann-La Roche Ag 7-podstawione związki sulfonimidoilopurynonowe do leczenia i profilaktyki zakażeń wirusowych
EP3512556B1 (en) 2016-09-13 2021-08-18 F. Hoffmann-La Roche AG Combined treatment with a tlr7 agonist and an hbv capsid assembly inhibitor
JP7328977B2 (ja) * 2018-02-12 2023-08-17 エフ． ホフマン－ラ ロシュ アーゲー ウイルス感染の処置および予防のための新規のスルホン化合物および誘導体
JP7089596B2 (ja) * 2018-02-28 2022-06-22 エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト 肝がんの治療及び予防のための７位置換スルホンイミドイルプリノン化合物及び誘導体

Also Published As

Publication number Publication date
JPH11193282A (ja) 1999-07-21

Similar Documents

Publication Publication Date Title
JP4189048B2 (ja) 複素環化合物
JP4375901B2 (ja) 新規な複素環化合物
JP4472693B2 (ja) ９置換−８−オキソアデニン化合物
JP4497340B2 (ja) ピリミジン誘導体
JPWO1999028321A1 (ja) 新規な複素環化合物
JP3315983B2 (ja) １−置換 １Ｈ−イミダゾ（４，５−ｃ）キノリン−４−アミン，中間体及び医薬用組成物
RU2127734C1 (ru) Производные пиридопиримидина, их получение, фармацевтическая композиция, способ лечения
JPH11180981A (ja) 複素環誘導体
JP4890723B2 (ja) ＴＮＦαインヒビターとして有用なクマリン誘導体
KR100338610B1 (ko) 인다졸 유도체 및 포스포디에스터라제 (pde) 유형 iv 및 종양괴사인자 (tnf) 생산의 억제제로서 그의 용도
JPWO2000012487A1 (ja) ピリミジン誘導体
JPWO2005092892A1 (ja) ８−オキソアデニン化合物
JP4342007B2 (ja) キナゾリン誘導体
JPH09500376A (ja) Ｐｄｅ−ｉｖ阻害活性を有する新規化合物
JP4315300B2 (ja) 新規なキナゾリン誘導体
JPH08502721A (ja) 医薬的に活性な二環式‐複素環アミン
US20070179149A1 (en) Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
JPH11106340A (ja) Ｓｔａｔ６活性化阻害剤
CN113549080A (zh) 一类1,2,3-三氮唑并嘧啶类化合物、其制备方法和用途
JP4248245B2 (ja) ６−フェニルベンゾナフチリジン
JP5094725B2 (ja) Ｈｉｖインテグラーゼ阻害剤
JP2000229959A (ja) Ｓｔａｔ６活性化阻害剤
CN115003300A (zh) Jak抑制剂
KR20060092220A (ko) 유도성 ｎｏ-신타아제 저해제로서의 이미다조피리딘 유도체
JPH06503814A (ja) 置換三環式化合物

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041111

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041111

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20041111

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20041111

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050210

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20051026

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080617

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080618

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080806

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080902

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080912

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110919

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees